Report
BioNTech SE : FY due 30 March - Guidance to be met, focus on Comirnaty in 2022
>Reducing our forecast for FY 2021, still seeing the high end of guidance - Pfizer reported FY 2021 sales of c. $ 36bn for Comirnaty based on 2.2bn doses shipped in FY 2021. We estimate that this does not include all international sales (only in the numbers until the end of November according to our estimates). Nevertheless, we had 3bn doses to be shipped under the Pfizer agreement in our model, which we now estimate to have been 2.5bn. We also exclude 100m doses fro...
Underlying
BioNTech SE
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Martial Descoutures
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.